These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2801784)

  • 1. Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis.
    Bolton WK; Sturgill BC
    Am J Nephrol; 1989; 9(5):368-75. PubMed ID: 2801784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose corticosteroids: their use in treating idiopathic rapidly progressive glomerulonephritis.
    O'Neill WM; Etheridge WB; Bloomer HA
    Arch Intern Med; 1979 May; 139(5):514-8. PubMed ID: 443944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of aggressively treated idiopathic rapidly progressive glomerulonephritis.
    Bruns FJ; Adler S; Fraley DS; Segel DP
    Am J Med; 1989 Apr; 86(4):400-6. PubMed ID: 2929626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations.
    Bolton WK; Innes DJ; Sturgill BC; Kaiser DL
    Kidney Int; 1987 Dec; 32(6):869-76. PubMed ID: 3501499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis.
    Bolton WK; Couser WG
    Am J Med; 1979 Mar; 66(3):495-502. PubMed ID: 433955
    [No Abstract]   [Full Text] [Related]  

  • 7. Progression of membranous nephropathy to acute crescentic rapidly progressive glomerulonephritis and response to pulse methylprednisolone.
    Koethe JD; Gerig JS; Glickman JL; Sturgill BC; Bolton WK
    Am J Nephrol; 1986; 6(3):224-8. PubMed ID: 3740132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Steroid pulse therapy in rapidly progressive glomerulonephritis].
    Ogi M; Yoshimura M; Ikeda K; Saito Y; Kida H; Sugioka G; Watanabe K
    Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):669-75. PubMed ID: 1479706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone pulse therapy in rapidly progressive glomerulonephritis.
    de Glas-Vos JW; Krediet RT; Arisz L
    Neth J Med; 1991 Apr; 38(3-4):96-103. PubMed ID: 1881508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA deposits along glomerular basement membranes in rapidly progressive glomerulonephritis.
    Cai G; Chen P; Wu D; Shi S; Yin Z; Zhang X; Wei R; Chen X
    South Med J; 2008 Sep; 101(9):945-7. PubMed ID: 18708970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
    Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of methylprednisolone pulse therapy in the insidious type of crescentic glomerulonephritis].
    Takeda S; Kida H; Takazakura E; Yokoyama H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):490-6. PubMed ID: 9379560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The increase of antiglomerular basement membrane antibody following pauci-immune-type crescentic glomerulonephritis.
    Kitagawa W; Miura N; Yamada H; Nishikawa K; Futenma A; Imai H
    Clin Exp Nephrol; 2005 Mar; 9(1):69-73. PubMed ID: 15830277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis.
    Tang Z; Zhou H; Yao X; Hu W; Leishi L
    Chin Med J (Engl); 1997 Mar; 110(3):206-9. PubMed ID: 9594342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crescentic post-streptococcal glomerulonephritis with nephrotic syndrome in the adult: is aggressive therapy warranted?
    Raff A; Hebert T; Pullman J; Coco M
    Clin Nephrol; 2005 May; 63(5):375-80. PubMed ID: 15909597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group.
    Cole E; Cattran D; Magil A; Greenwood C; Churchill D; Sutton D; Clark W; Morrin P; Posen G; Bernstein K
    Am J Kidney Dis; 1992 Sep; 20(3):261-9. PubMed ID: 1519607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
    Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
    BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cyclophosphamide and corticosteroid-induced remission in severe glomerulopathy associated with systemic vasculitis.
    Rubinger D; Drukker A; Shvil Y; Kopolovic Y; Friedlaender MM; Shalit M; Popovtzer MM
    Am J Nephrol; 1986; 6(5):346-52. PubMed ID: 2881483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.